应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RYTM Rhythm Pharmaceuticals Inc.
盘前交易 07-10 07:57:23 EDT
89.00
+23.86
+36.63%
盘前
87.70
-1.30
-1.46%
07:54 EDT
最高
89.05
最低
75.01
成交量
479.69万
今开
76.75
昨收
65.14
日振幅
21.55%
总市值
56.62亿
流通市值
45.83亿
总股本
6,362万
成交额
4.04亿
换手率
9.32%
流通股本
5,149万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Rhythm Pharmaceuticals, Inc.盘中异动 早盘股价大涨16.67%报76.00美元
市场透视 · 07-09 13:31
Rhythm Pharmaceuticals, Inc.盘中异动 早盘股价大涨16.67%报76.00美元
Stifel:维持Rhythm Pharmaceuticals(RYTM.US)评级,由买入调整至买入评级, 目标价由78.00美元调整至94.00美元。
金融界 · 05-29
Stifel:维持Rhythm Pharmaceuticals(RYTM.US)评级,由买入调整至买入评级, 目标价由78.00美元调整至94.00美元。
美国银行:这些强势股被低配但具备上涨动能
老虎资讯综合 · 05-28
美国银行:这些强势股被低配但具备上涨动能
Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘快速下挫5.16%报59.14美元
市场透视 · 05-27
Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘快速下挫5.16%报59.14美元
Rhythm Pharmaceuticals, Inc.盘中异动 股价大涨5.06%
市场透视 · 05-15
Rhythm Pharmaceuticals, Inc.盘中异动 股价大涨5.06%
Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.01%报57.68美元
市场透视 · 05-09
Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.01%报57.68美元
Rhythm Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.07%报61.36美元
市场透视 · 05-08
Rhythm Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.07%报61.36美元
Rhythm Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.01%报48.25美元
市场透视 · 03-10
Rhythm Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.01%报48.25美元
大摩:假定Rhythm Pharmaceuticals(RYTM.US)增持评级, 目标价由72.00美元调整至72.00美元。
金融界 · 03-07
大摩:假定Rhythm Pharmaceuticals(RYTM.US)增持评级, 目标价由72.00美元调整至72.00美元。
Stifel:重申Rhythm Pharmaceuticals(RYTM.US)买入评级, 目标价78.00美元。
金融界 · 03-05
Stifel:重申Rhythm Pharmaceuticals(RYTM.US)买入评级, 目标价78.00美元。
Rhythm Pharmaceuticals, Inc.2024财年实现净利润-2.61亿美元,同比减少41.08%
市场透视 · 03-02
Rhythm Pharmaceuticals, Inc.2024财年实现净利润-2.61亿美元,同比减少41.08%
加拿大投资银行集团:维持Rhythm Pharmaceuticals(RYTM.US)评级,由买入调整至买入评级, 目标价由80.00美元调整至81.00美元。
金融界 · 02-27
加拿大投资银行集团:维持Rhythm Pharmaceuticals(RYTM.US)评级,由买入调整至买入评级, 目标价由80.00美元调整至81.00美元。
异动解读 | Rhythm Pharmaceuticals公布2024年Q4财报出色 盘中股价大涨5%
异动解读 · 02-26
异动解读 | Rhythm Pharmaceuticals公布2024年Q4财报出色 盘中股价大涨5%
Rhythm Pharmaceuticals, Inc.盘中异动 大幅拉升5.00%
市场透视 · 02-26
Rhythm Pharmaceuticals, Inc.盘中异动 大幅拉升5.00%
Rhythm Pharmaceuticals(RYTM.US):2024年Q4财报实现营收4183万美元,前值为2423.4万美元,预期值为3848万美元;每股收益为-0.72美元,前值为-0.70美元,预期值为-0.73美元。
金融界 · 02-26
Rhythm Pharmaceuticals(RYTM.US):2024年Q4财报实现营收4183万美元,前值为2423.4万美元,预期值为3848万美元;每股收益为-0.72美元,前值为-0.70美元,预期值为-0.73美元。
Rhythm Pharmaceuticals第四季度每股盈余$(0.72),符合预期,销售额4183万美元,超出预期3848万美元
财报速递 · 02-26
Rhythm Pharmaceuticals第四季度每股盈余$(0.72),符合预期,销售额4183万美元,超出预期3848万美元
Rhythm Pharmaceuticals, Inc.盘中异动 急速下挫5.04%报51.91美元
市场透视 · 02-25
Rhythm Pharmaceuticals, Inc.盘中异动 急速下挫5.04%报51.91美元
Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘大幅拉升5.06%
市场透视 · 01-21
Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘大幅拉升5.06%
Rhythm Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.00%
市场透视 · 01-02
Rhythm Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.00%
Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘大幅跳水5.02%报53.95美元
市场透视 · 2024-12-18
Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘大幅跳水5.02%报53.95美元
加载更多
公司概况
公司名称:
Rhythm Pharmaceuticals Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Rhythm Pharmaceuticals, Inc.是一家特拉华州的公司,成立于2013年2月。该公司是一家全球性、商业阶段的生物制药公司,致力于改变患有罕见神经内分泌疾病的患者及其家人的生活。该公司专注于推进黑皮质素-4受体激动剂,包括他们的主要资产IMCIVREE,作为一种精准药物,旨在治疗由罕见的MC4R通路疾病引起的食欲亢进和严重肥胖。
发行价格:
--
{"stockData":{"symbol":"RYTM","market":"US","secType":"STK","nameCN":"Rhythm Pharmaceuticals Inc.","latestPrice":89,"timestamp":1752091200000,"preClose":65.14,"halted":0,"volume":4796917,"hourTrading":{"tag":"盘前","latestPrice":87.7,"preClose":89,"latestTime":"07:54 EDT","volume":2860,"amount":250054.44749999998,"timestamp":1752148495022},"delay":0,"floatShares":51489805,"shares":63621472,"eps":-2.819319,"marketStatus":"盘前交易","change":23.86,"latestTime":"07-10 07:57:23 EDT","open":76.75,"high":89.05,"low":75.01,"amount":404355063.19326,"amplitude":0.215536,"askPrice":87.9,"askSize":40,"bidPrice":87.51,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-2.819319,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752154200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1507176000000,"exchange":"NASDAQ","adjPreClose":89,"preHourTrading":{"tag":"盘前","latestPrice":87.7,"preClose":89,"latestTime":"07:54 EDT","volume":2860,"amount":250054.44749999998,"timestamp":1752148495022},"postHourTrading":{"tag":"盘后","latestPrice":87.9845,"preClose":89,"latestTime":"19:59 EDT","volume":137186,"amount":12159759.2787,"timestamp":1752105590884},"volumeRatio":6.106187099008803,"impliedVol":0.6155,"impliedVolPercentile":0.739},"requestUrl":"/m/hq/s/RYTM","defaultTab":"news","newsList":[{"id":"2550428653","title":"Rhythm Pharmaceuticals, Inc.盘中异动 早盘股价大涨16.67%报76.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550428653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550428653?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:31","pubTimestamp":1752067911,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时31分,Rhythm Pharmaceuticals, Inc.股票出现异动,股价大幅拉升16.67%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.29%。Rhythm Pharmaceuticals, Inc.公司简介:Rhythm Pharmaceuticals Inc 是一家商业阶段的生物制药公司。消息层面,截至21时31分,《Leerink Partners首予Rhythm Pharmaceuticals买入评级,目标价88美元》资讯为影响Rhythm Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213152a69f8c3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213152a69f8c3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","RYTM","BK4588","BK4139"],"gpt_icon":0},{"id":"2539260519","title":"Stifel:维持Rhythm Pharmaceuticals(RYTM.US)评级,由买入调整至买入评级, 目标价由78.00美元调整至94.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2539260519","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539260519?lang=zh_cn&edition=full","pubTime":"2025-05-30 01:36","pubTimestamp":1748540198,"startTime":"0","endTime":"0","summary":"Stifel:维持Rhythm Pharmaceuticals(RYTM.US)评级,由买入调整至买入评级, 目标价由78.00美元调整至94.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/30013650752926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RYTM"],"gpt_icon":0},{"id":"1122852068","title":"美国银行:这些强势股被低配但具备上涨动能","url":"https://stock-news.laohu8.com/highlight/detail?id=1122852068","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122852068?lang=zh_cn&edition=full","pubTime":"2025-05-28 13:42","pubTimestamp":1748410964,"startTime":"0","endTime":"0","summary":"根据美国银行的分析, $特许通讯 $ 和 $Toast, Inc.$ 等少数几只被市场忽视的股票未来可能迎来上涨机会。随着特朗普撤销或推迟了4月初宣布的诸多关税措施,美股持续走高。自4月7日触及盘中低点以来,标普500指数已飙升超过20%。在近期给客户的研究报告中,美国银行重点指出了一批基金低配且具备上涨催化剂的股票。该公司股价年内已上涨20%。为波音飞机提供零部件的 $Howmet Aerospace Inc.$ 年内涨幅约54%,周二股价创52周新高。","market":"us","thumbnail":"https://community-static.tradeup.com/news/d03be9590c04791edefbb7032be32acc","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/d03be9590c04791edefbb7032be32acc"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0f5c3dde7b77f1dd5a82843c00b27f9f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美国银行:这些强势股被低配但具备上涨动能","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNP","TOST","CPRT","RYTM","CHKP","HWM","CHTR"],"gpt_icon":0},{"id":"2538943604","title":"Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘快速下挫5.16%报59.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538943604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538943604?lang=zh_cn&edition=full","pubTime":"2025-05-28 03:44","pubTimestamp":1748375096,"startTime":"0","endTime":"0","summary":"北京时间2025年05月28日03时44分,Rhythm Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.16%。截至发稿,该股报59.14美元/股,成交量33.2654万股,换手率0.52%,振幅5.54%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.07%。其相关个股中,Imunon, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Nucana Plc、Imunon, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为703.91%、477.63%、260.20%,振幅较大的相关个股有Imunon, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Apollomics Inc C/Wts 01/04/2028 ,振幅分别为118.97%、74.51%、61.32%。Rhythm Pharmaceuticals, Inc.公司简介:Rhythm Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505280344569504a8da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505280344569504a8da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2535543875","title":"Rhythm Pharmaceuticals, Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535543875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535543875?lang=zh_cn&edition=full","pubTime":"2025-05-16 00:00","pubTimestamp":1747324842,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日00时00分,Rhythm Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.06%。截至发稿,该股报60.18美元/股,成交量18.7326万股,换手率0.29%,振幅4.73%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.50%。其相关个股中,Nucana Plc、Cabaletta Bio, Inc.、Renovaro Inc.涨幅较大,Nucana Plc、Polyrizon Ltd.、Abpro Holdings, Inc较为活跃,换手率分别为12000.13%、4403.45%、301.47%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nucana Plc、Briacell Therapeutics Corp C/Wts 26/02/2026,振幅分别为76.92%、63.87%、60.27%。Rhythm Pharmaceuticals, Inc.公司简介:Rhythm Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516000042a6e08e2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516000042a6e08e2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","RYTM","BK4139"],"gpt_icon":0},{"id":"2534450799","title":"Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.01%报57.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534450799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534450799?lang=zh_cn&edition=full","pubTime":"2025-05-10 03:38","pubTimestamp":1746819504,"startTime":"0","endTime":"0","summary":"北京时间2025年05月10日03时38分,Rhythm Pharmaceuticals, Inc.股票出现波动,股价大幅下挫5.01%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为3.58%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Osr Holdings Inc C/Wts 09/02/2028 、Phathom Pharmaceuticals, Inc.涨幅较大,Nucana Plc、Polyrizon Ltd.、Pasithea Therapeutics Corp.较为活跃,换手率分别为2188.43%、178.85%、63.78%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Geovax Labs Inc C/Wts 29/09/2025、Liminatus Pharma Inc C/Wts 30/04/2030 ,振幅分别为150.95%、96.73%、65.30%。Rhythm Pharmaceuticals, Inc.公司简介:Rhythm Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051003382494f214fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051003382494f214fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4588","RYTM"],"gpt_icon":0},{"id":"2533139276","title":"Rhythm Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.07%报61.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533139276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533139276?lang=zh_cn&edition=full","pubTime":"2025-05-08 22:02","pubTimestamp":1746712930,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日22时02分,Rhythm Pharmaceuticals, Inc.股票出现异动,股价急速跳水5.07%。截至发稿,该股报61.36美元/股,成交量7.2467万股,换手率0.11%,振幅5.41%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为2.87%。Rhythm Pharmaceuticals, Inc.公司简介:Rhythm Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508220210a6d7cc84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508220210a6d7cc84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4588","RYTM"],"gpt_icon":0},{"id":"2518276046","title":"Rhythm Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.01%报48.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518276046?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:30","pubTimestamp":1741617055,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时30分,Rhythm Pharmaceuticals, Inc.股票出现异动,股价大幅下挫5.01%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。其相关个股中,Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃,换手率分别为3457.49%、730.68%、517.45%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.,振幅分别为41.36%、40.33%、40.24%。Rhythm Pharmaceuticals, Inc.公司简介:Rhythm Pharmaceuticals Inc 是一家生物制药公司,从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223055964044b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223055964044b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","RYTM","BK4588","BK4139"],"gpt_icon":0},{"id":"2517456009","title":"大摩:假定Rhythm Pharmaceuticals(RYTM.US)增持评级, 目标价由72.00美元调整至72.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517456009","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517456009?lang=zh_cn&edition=full","pubTime":"2025-03-08 01:53","pubTimestamp":1741369983,"startTime":"0","endTime":"0","summary":"大摩:假定Rhythm Pharmaceuticals(RYTM.US)增持评级, 目标价由72.00美元调整至72.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08015348605007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RYTM"],"gpt_icon":0},{"id":"2517404949","title":"Stifel:重申Rhythm Pharmaceuticals(RYTM.US)买入评级, 目标价78.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517404949","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517404949?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:01","pubTimestamp":1741197678,"startTime":"0","endTime":"0","summary":"Stifel:重申Rhythm Pharmaceuticals(RYTM.US)买入评级, 目标价78.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06020148550854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RYTM"],"gpt_icon":0},{"id":"2516480445","title":"Rhythm Pharmaceuticals, Inc.2024财年实现净利润-2.61亿美元,同比减少41.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516480445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516480445?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:00","pubTimestamp":1740931238,"startTime":"0","endTime":"0","summary":"3月3日,Rhythm Pharmaceuticals, Inc.公布财报,公告显示公司2024财年净利润为-2.61亿美元,同比减少41.08%;其中营业收入为1.30亿美元,同比增加67.89%,每股基本收益为-4.34美元。机构评级:截至2025年3月3日,当前有11家机构对Rhythm Pharmaceuticals, Inc.目标价做出预测,其中目标均价为74.73美元,其中最低目标价为60.00美元,最高目标价为94.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000058abe4aca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000058abe4aca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM"],"gpt_icon":0},{"id":"2514733235","title":"加拿大投资银行集团:维持Rhythm Pharmaceuticals(RYTM.US)评级,由买入调整至买入评级, 目标价由80.00美元调整至81.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514733235","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514733235?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:11","pubTimestamp":1740687119,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团:维持Rhythm Pharmaceuticals(RYTM.US)评级,由买入调整至买入评级, 目标价由80.00美元调整至81.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28041148442125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RYTM"],"gpt_icon":0},{"id":"1168826920","title":"异动解读 | Rhythm Pharmaceuticals公布2024年Q4财报出色 盘中股价大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168826920","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168826920?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:06","pubTimestamp":1740593190,"startTime":"0","endTime":"0","summary":"Rhythm Pharmaceuticals Inc. (RYTM)今日盘中大涨5.01%,引起了市场的广泛关注。\n\n公司发布的2024年第四季度财报显示营收实现4183万美元,超出市场预期的3848万美元。公司每股亏损0.72美元,则符合了市场对亏损0.73美元的预期。\n\n从财报数据看,公司营收同比大增72.61%,业绩优于市场预期。因此公司财报出色是导致今日股价上涨的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RYTM"],"gpt_icon":0},{"id":"2514145866","title":"Rhythm Pharmaceuticals, Inc.盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514145866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514145866?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:05","pubTimestamp":1740593153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时05分,Rhythm Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.00%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.40%。其相关个股中,Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Renovaro Inc.涨幅较大,Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃,换手率分别为6389.14%、258.52%、239.59%,振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Pds Biotechnology Corporation,振幅分别为194.07%、49.18%、44.44%。Rhythm Pharmaceuticals, Inc.公司简介:Rhythm Pharmaceuticals Inc 是一家生物制药公司,从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227020553abde1c3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227020553abde1c3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","RYTM","BK4139"],"gpt_icon":0},{"id":"2514831857","title":"Rhythm Pharmaceuticals(RYTM.US):2024年Q4财报实现营收4183万美元,前值为2423.4万美元,预期值为3848万美元;每股收益为-0.72美元,前值为-0.70美元,预期值为-0.73美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514831857","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514831857?lang=zh_cn&edition=full","pubTime":"2025-02-26 20:11","pubTimestamp":1740571870,"startTime":"0","endTime":"0","summary":"Rhythm Pharmaceuticals(RYTM.US):2024年Q4财报实现营收4183万美元,前值为2423.4万美元,预期值为3848万美元;每股收益为-0.72美元,前值为-0.70美元,预期值为-0.73美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26201148410993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RYTM"],"gpt_icon":0},{"id":"1187635106","title":"Rhythm Pharmaceuticals第四季度每股盈余$(0.72),符合预期,销售额4183万美元,超出预期3848万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187635106","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187635106?lang=zh_cn&edition=full","pubTime":"2025-02-26 20:10","pubTimestamp":1740571844,"startTime":"0","endTime":"0","summary":"Rhythm Pharmaceuticals 公布季度每股亏损$,符合分析师一致预期。公司报告季度销售额为4183万美元,超出分析师一致预期的3848万美元,增长8.69%。相比去年同期销售额2423万美元,增加了72.61%。以上内容来自Benzinga Earnings专栏,原文如下:Rhythm Pharmaceuticals reported quarterly losses of $ per share which met the analyst consensus estimate. This is a 2.86 percent decrease over losses of $ per share from the same period last year. The company reported quarterly sales of $41.83 million which beat the analyst consensus estimate of $38.48 million by 8.69 percent. This is a 72.61 percen","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Rhythm Pharmaceuticals第四季度每股盈余$(0.72),符合预期,销售额4183万美元,超出预期3848万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RYTM"],"gpt_icon":0},{"id":"2514118360","title":"Rhythm Pharmaceuticals, Inc.盘中异动 急速下挫5.04%报51.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514118360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514118360?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:08","pubTimestamp":1740499725,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时08分,Rhythm Pharmaceuticals, Inc.股票出现异动,股价急速跳水5.04%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.74%。其相关个股中,Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大,Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为1246.54%、1101.53%、849.54%,振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc,振幅分别为224.93%、87.83%、64.05%。Rhythm Pharmaceuticals, Inc.公司简介:Rhythm Pharmaceuticals Inc 是一家生物制药公司,从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226000845963007df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226000845963007df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","RYTM","BK4139"],"gpt_icon":0},{"id":"2505784147","title":"Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘大幅拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505784147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505784147?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:50","pubTimestamp":1737492623,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时50分,Rhythm Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.06%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.76%。其相关个股中,Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大,Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃,换手率分别为1753.49%、530.91%、192.36%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 ,振幅分别为103.72%、96.32%、69.14%。Rhythm Pharmaceuticals, Inc.公司简介:Rhythm Pharmaceuticals Inc 是一家生物制药公司,从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122045024a22aa3f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122045024a22aa3f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2500975669","title":"Rhythm Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500975669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500975669?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:29","pubTimestamp":1735831795,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时29分,Rhythm Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.00%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.90%。其相关个股中,Revelation Biosciences Inc C/Wts 10/01/2027 、Revelation Biosciences, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大,Revelation Biosciences, Inc.、知临集团、Onconetix, Inc.较为活跃,换手率分别为1090.54%、110.82%、48.53%,振幅较大的相关个股有Revelation Biosciences, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为125.57%、98.57%、78.14%。Rhythm Pharmaceuticals, Inc.公司简介:Rhythm Pharmaceuticals Inc 是一家生物制药公司,从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010223295598590957&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010223295598590957&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4139","RYTM"],"gpt_icon":0},{"id":"2492515801","title":"Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘大幅跳水5.02%报53.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492515801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492515801?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:39","pubTimestamp":1734554366,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时39分,Rhythm Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.02%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为2.80%。其相关个股中,Polyrizon Ltd.、Tc Biopharm Plc C/Wts 10/02/2028 、Surrozen Inc C/Wts 01/08/2031 涨幅较大,Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm Plc较为活跃,换手率分别为3229.00%、677.93%、350.85%,振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025,振幅分别为227.62%、145.02%、105.17%。Rhythm Pharmaceuticals, Inc.公司简介:Rhythm Pharmaceuticals Inc 是一家生物制药公司,从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904392695ea5add&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904392695ea5add&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","RYTM","BK4588","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rhythmtx.com","stockEarnings":[{"period":"1week","weight":0.3299},{"period":"1month","weight":0.3339},{"period":"3month","weight":0.539},{"period":"6month","weight":0.5845},{"period":"1year","weight":0.9804},{"period":"ytd","weight":0.5899}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rhythm Pharmaceuticals, Inc.是一家特拉华州的公司,成立于2013年2月。该公司是一家全球性、商业阶段的生物制药公司,致力于改变患有罕见神经内分泌疾病的患者及其家人的生活。该公司专注于推进黑皮质素-4受体激动剂,包括他们的主要资产IMCIVREE,作为一种精准药物,旨在治疗由罕见的MC4R通路疾病引起的食欲亢进和严重肥胖。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.053118},{"month":2,"riseRate":0.375,"avgChangeRate":-0.043141},{"month":3,"riseRate":0.125,"avgChangeRate":-0.055987},{"month":4,"riseRate":0.625,"avgChangeRate":0.023443},{"month":5,"riseRate":0.25,"avgChangeRate":-0.062002},{"month":6,"riseRate":0.5,"avgChangeRate":0.046517},{"month":7,"riseRate":0.5,"avgChangeRate":0.289186},{"month":8,"riseRate":0.714286,"avgChangeRate":0.243579},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.043398},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.035366},{"month":11,"riseRate":0.875,"avgChangeRate":0.159256},{"month":12,"riseRate":0.625,"avgChangeRate":0.048832}],"exchange":"NASDAQ","name":"Rhythm Pharmaceuticals Inc.","nameEN":"Rhythm Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rhythm Pharmaceuticals Inc.(RYTM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rhythm Pharmaceuticals Inc.(RYTM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rhythm Pharmaceuticals Inc.,RYTM,Rhythm Pharmaceuticals Inc.股票,Rhythm Pharmaceuticals Inc.股票老虎,Rhythm Pharmaceuticals Inc.股票老虎国际,Rhythm Pharmaceuticals Inc.行情,Rhythm Pharmaceuticals Inc.股票行情,Rhythm Pharmaceuticals Inc.股价,Rhythm Pharmaceuticals Inc.股市,Rhythm Pharmaceuticals Inc.股票价格,Rhythm Pharmaceuticals Inc.股票交易,Rhythm Pharmaceuticals Inc.股票购买,Rhythm Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rhythm Pharmaceuticals Inc.(RYTM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rhythm Pharmaceuticals Inc.(RYTM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}